Semaglutid

Semaglutid is a pharmaceutical drug developed by the Danish company Novo Nordisk. It is used for the treatment of type 2 diabetes and obesity. The drug is manufactured in multiple countries, including Denmark, where Novo Nordisk is headquartered. As a pharmaceutical product, Semaglutid is not a food item, and therefore, health information is not applicable.